These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24374223)

  • 41. Aerosolization behavior of carrier-free L-leucine coated salbutamol sulphate powders.
    Raula J; Lähde A; Kauppinen EI
    Int J Pharm; 2009 Jan; 365(1-2):18-25. PubMed ID: 18789380
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimized aerosol delivery to a mechanically ventilated rodent.
    MacLoughlin RJ; Higgins BD; Laffey JG; O'Brien T
    J Aerosol Med Pulm Drug Deliv; 2009 Dec; 22(4):323-32. PubMed ID: 19415985
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Do all dry powder inhalers show the same pharmaceutical performance?
    Taylor A; Gustafsson P
    Int J Clin Pract Suppl; 2005 Dec; (149):7-12. PubMed ID: 16279997
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of particle diameter on aerosolization performance and release of budesonide loaded mesoporous silica particles.
    van der Zwaan I; Pilkington GA; Frenning G; Ekström M; Valetti S; Pitcairn GR; Feiler A
    Eur J Pharm Sci; 2024 Sep; 200():106828. PubMed ID: 38862047
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Albuterol delivery via intrapulmonary percussive ventilator and jet nebulizer in a pediatric ventilator model.
    Berlinski A; Willis JR
    Respir Care; 2010 Dec; 55(12):1699-704. PubMed ID: 21122179
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adhesion forces in interactive mixtures for dry powder inhalers--evaluation of a new measuring method.
    Lohrmann M; Kappl M; Butt HJ; Urbanetz NA; Lippold BC
    Eur J Pharm Biopharm; 2007 Sep; 67(2):579-86. PubMed ID: 17418548
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modeling dispersion of dry powders for inhalation. The concepts of total fines, cohesive energy and interaction parameters.
    Thalberg K; Berg E; Fransson M
    Int J Pharm; 2012 May; 427(2):224-33. PubMed ID: 22349053
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aerosol delivery from a metered-dose inhaler during mechanical ventilation. An in vitro model.
    Fink JB; Dhand R; Duarte AG; Jenne JW; Tobin MJ
    Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):382-7. PubMed ID: 8756810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Novel In-Line Delivery System to Administer Dry Powder Mannitol to Mechanically Ventilated Patients.
    Feng B; Tang P; Leung SS; Dhanani J; Chan HK
    J Aerosol Med Pulm Drug Deliv; 2017 Apr; 30(2):100-107. PubMed ID: 27754730
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Basic techniques for aerosol delivery during mechanical ventilation.
    Dhand R
    Respir Care; 2004 Jun; 49(6):611-22. PubMed ID: 15165296
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro delivery of aerosolized treprostinil via modern mechanical ventilation.
    Patel RB; Smaldone GC; Cuccia AD; Strachan P
    J Aerosol Med Pulm Drug Deliv; 2013 Aug; 26(4):200-7. PubMed ID: 23668545
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aerosol electrostatics. I: Properties of fine powders before and after aerosolization by dry powder inhalers.
    Byron PR; Peart J; Staniforth JN
    Pharm Res; 1997 Jun; 14(6):698-705. PubMed ID: 9210184
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rational design of a dry powder inhaler: device design and optimisation.
    Friebel C; Steckel H; Müller BW
    J Pharm Pharmacol; 2012 Sep; 64(9):1303-15. PubMed ID: 22881442
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors affecting bronchodilator delivery in mechanically ventilated adults.
    Ari A; Fink JB
    Nurs Crit Care; 2010; 15(4):192-203. PubMed ID: 20626796
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of a Soluplus budesonide freeze-dried powder for nasal drug delivery.
    Pozzoli M; Traini D; Young PM; Sukkar MB; Sonvico F
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1510-1518. PubMed ID: 28425305
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A survey of albuterol administration practices in intubated patients in the neonatal intensive care unit.
    Ballard J; Lugo RA; Salyer JW
    Respir Care; 2002 Jan; 47(1):31-8. PubMed ID: 11749685
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler.
    Kemp JP; Hill MR; Vaughan LM; Meltzer EO; Welch MJ; Ostrom NK
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):322-6. PubMed ID: 9357377
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel, versatile valved holding chamber for delivering inhaled medications to neonates and small children: laboratory simulation of delivery options.
    DiBlasi RM; Coppolo DP; Nagel MW; Doyle CC; Avvakoumova VI; Ali RS; Mitchell JP
    Respir Care; 2010 Apr; 55(4):419-26. PubMed ID: 20406509
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Delivery of salbutamol and of budesonide from a novel multi-dose inhaler Airmax.
    Zeng XM; O'Leary D; Phelan M; Jones S; Colledge J
    Respir Med; 2002 Jun; 96(6):404-11. PubMed ID: 12117039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.